期刊文献+

杜少辉辨治乳腺癌术后并发症经验

Experience of Professor DU Shao-Hui in Treating Postoperative Complications of Breast Cancer
原文传递
导出
摘要 总结杜少辉教授治疗乳腺癌术后各类并发症的辨证思路及用药经验。杜少辉教授认为乳腺癌之发病机制与正虚而致的痰、瘀、毒密切相关,并强调少阳厥阴枢机不利在乳腺癌术后的基本病机作用,乳腺癌术后各类并发症的调治必须考虑到乳腺癌的病机特点。按照"阴阳为纲,六经分治"的辨证方法分别论治,临床上常用柴胡类方合吴茱萸汤以调畅肝胆气机,暖肝降胃,使一身气血运行通畅,则诸证可缓。 The dialectical thinking and clinical experience of Professor DU Shao-Hui in treating variouscomplications after breast cancer surgery were summarized. In Professor DU's opinion,the pathogenesis of breastcancer is associated with phlegm, blood stasis and heat-toxicity due to healthy-Qi deficiency, and thedisharmony of Shaoyang-Jueyin pivot was emphasized. The treatment of various complications after breast cancersurgery should follow the pathogenesis of breast cancer. The therapeutic principle for postoperative breast cancerpatients should be based on yin-yang differentiation and six-meridian differentiation, and recipes includingRadix Bupleuri Decoction and Fructus Evodiae Decoction were frequently used to regulate liver and gall-bladderQi,warm liver and descend stomach-Qi,thus to activate the general Qi and blood through regulating ShaoyangJueyin pivot.
作者 陶璐 杜少辉 TAO Lu;Advisor: DU Shao-Hui(The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518000 Guangdong, China;Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518000 Guangdong, China)
出处 《广州中医药大学学报》 CAS 2018年第4期738-741,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(编号:81173377)
关键词 乳腺癌 术后并发症 六经辨证 调畅肝胆气机 杜少辉 breast cancer postoperative complications six-meridian differentiation regulating liver and gallbladder Qi DU Shao-Hui
  • 相关文献

参考文献2

二级参考文献37

  • 1韦尉东,王欣,戎铁华,黄植蕃,李宝江.乳腺癌手术保留肋间臂神经的方法及临床意义[J].中华外科杂志,2005,43(17):1136-1138. 被引量:47
  • 2Jemal A, Bray F, Center MM,et al. Global cancer statistics[ J].CA Cancer J Clin, 2011,61(2) : 69-90.
  • 3Kesson E,MAllardiceGM, GeorgeWD, et al. Effects of multidisci-plinary team working on breast cancer survival : retrospective,comparative, interventional cohort study of 13 722 women [ J/OL], BMJ, 2012[ 2015-05-20]. http://www.bmj.com/content/344/bmj. e2718344: e2718.
  • 4GreeneFL, FleminglD. AJCC 肿瘤分期手册[M]. 6 版.北京:中国医药科技出版社,2009:20-22.
  • 5Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:international expert consensus on the primarytherapy of earlybreast cancer 2005[ J] . Ann Oncol, 2005, 16( 10) : 1569-1583.
  • 6Carlson RW, Edge SB, Theriault RL,et al. NCCN: Breastcancer[ J]. Cancer Control, 2001, 8( Suppl 2) :54-61.
  • 7Stewart BW, Kleihues P. World cancer report[ M]. Lyon; IARCpress, 2003:188-193.
  • 8Lopez PT,van Bodegraven J,Winkens B ,et al. The quality of life in long-term breast cancer survivors with breast cancer re- lated lymphedema[Jl. Acta Chir Belg,2014,114(4):239-244.
  • 9Pusic AL,Cemal Y,Albornoz C,et al. Quality of life among breast cancer patients with |ymphedema:a systematic review of patient-reported outcome instruments and outcomes[J].J Can- cer Surviv,2013,7(1 ) :83-92.
  • 10Zhu Y,Xie Y,Liu F. Systemic analysis on risk factors for breast cancer-related lymphedema[J].Asian Pac J Cancer Prey,2014, 15(16) :6535-6541.

共引文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部